Cart
sales@molnova.com
Sibiriline
CAS No. 1346526-26-8
Sibiriline( Sibiriline )
Catalog No. M11395 CAS No. 1346526-26-8
A specific competitive RIPK1 inhibitor with IC50 of 1.03 uM, 100-fold less potent for RIPK3.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 873 | Get Quote |
|
| 50MG | 1782 | Get Quote |
|
| 100MG | 2250 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSibiriline
-
NoteResearch use only, not for human use.
-
Brief DescriptionA specific competitive RIPK1 inhibitor with IC50 of 1.03 uM, 100-fold less potent for RIPK3.
-
DescriptionA specific competitive RIPK1 inhibitor with IC50 of 1.03 uM, 100-fold less potent for RIPK3; inhibits both TNF-induced RIPK1-dependent necroptosis and RIPK1-dependent apoptosis in FADD-deficient Jurkat cells (EC50=1.2 uM); selectively inhibits necroptotic cell death induced by various death ligands in human or mouse cells while not protecting from caspase-dependent apoptosis; protects mice from concanavalin A-induced hepatitis.
-
In Vitro——
-
In Vivo——
-
SynonymsSibiriline
-
PathwayApoptosis
-
TargetRIP kinase
-
RecptorRIP kinase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1346526-26-8
-
Formula Weight210.236
-
Molecular FormulaC13H10N2O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC1=CC=C(C2=CC3=CC=CN=C3N2)C=C1
-
Chemical Name4-(1H-Pyrrolo[2,3-b]pyridin-2-yl)phenol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Le Cann F, et al. FEBS J. 2017 Jul 17. doi: 10.1111/febs.14176.
molnova catalog
related products
-
RIPK1-IN-4
RIPK1-IN-4 is a potent and selective type II kinase receptor interacting protein 1 (RIP1) kinase inhibitor and binds to a DLG-out inactive form of RIP1 (IC50s of 16 nM and 10 nM for RIP1 and ADP-Glo kinase).
-
RIPK2-IN-2
A potent, selective receptor interacting protein-2 (RIP2) kinase inhibitor.
-
Zharp2-1
Zharp2-1, a RIPK2 inhibitor, inhibits the transcription of inflammatory cytokines induced by MDP-induced or Listeria monocytogenes infection and alleviates MDP-induced peritonitis symptoms in mice, which can be used for the study of inflammatory bowel disease (IBD).
